follitropin beta: Clinical Trials

54 trials of follitropin beta, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

38 completed, 8 unknown, 4 terminated, 2 recruiting. 20 Phase 4, 10 Phase 3, 6 Not applicable, 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 420Completed 11, Unknown 5, Terminated 2, Recruiting 1, Withdrawn 1
Phase 310Completed 9, Withdrawn 1
Not applicable6Completed 3, Recruiting 1, Terminated 1, Unknown 1
Phase 25Completed 3, Terminated 1, Unknown 1
Phase 12Completed 1, Unknown 1

Follow follitropin beta: new trials by email Literature Review of follitropin beta trials Research Report on follitropin beta

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitary Suppression With Medroxiprogesterona Acetate (MPA)
Corifolitropin Alfa, Folitropin Beta - Infertility, Female, Reproductive Sterility
Not applicableRecruitingInstituto Valenciano de Infertilidad, IVI VALENCIA3182025-07-082025-09-15
PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study
Elonva®, Puregon®, Orgalutran® - Ovarian Stimulation, Quality of Life
Phase 4RecruitingUniversity Hospital, Ghent602025-01-272025-12-26
Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.
150μg CFA (Elonva®) at stimulation day (SD) 1 and 100μg CFA(Elonva®) at SD 5, 150μg CFA (Elonva®) at SD 1 following by rFSH (Puregon®) 200IU daily from SD 8 until the day of the trigger - Fertility
Phase 3CompletedFundación Santiago Dexeus Font1942023-12-182026-06-23
Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells
Follitropin beta injection 150 IU, Follitropin beta injection 300 IU - Ovarian Function Insufficiency, Fertility Issues
Phase 1CompletedART Fertility Clinics LLC62023-07-052025-01-09
Reduction of Progesterone Elevation at Trigger in POR After Long Acting COS Compared With Daily COS: a Prospective Randomized Trial
Corifollitropin alfa, Follitropin Beta - Infertility
Phase 4CompletedIRCCS San Raffaele1102022-02-222024-05-16
Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders
A single Gonadotropin-Releasing Hormone (GnRH) antagonist corifollitropin alfa (CFA) stimulation, Up to three modified natural cycles with Follitropin beta. - Ovarian Reserve, Poor Responders
Phase 4UnknownUniversity Hospital, Ghent2082022-01-252024-05-09
Effect of Different Ovarian Stimulation Protocols on Endometrial Receptivity
CFA, rFSH, Fixed daily rFSH dosing protocol of 200-300 IU - Infertility, Female, Endometrial Diseases
Phase 4CompletedInstituto Valenciano de Infertilidade de Lisboa242020-01-292023-06-01
An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data
Follitropin Alfa, Follicle Stimulating Hormone/Luteinizing Hormone - Reproductive Issues, Reproductive Disorder
CompletedIVFarma LLC54842020-01-122021-10-22
Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient
Follitropin Beta;MSD, Ganirelix, hCG - Infertility
Not applicableCompletedReproductive & Genetic Hospital of CITIC-Xiangya5522017-11-152022-01-11
Optimisation of Follicular Recruitment in IVM Cycles
blood sampling, transvaginal ultrasound scanning, oocyte retrieval for IVM - Infertility, Female, Polycystic Ovary Syndrome
Phase 3CompletedUniversitair Ziekenhuis Brussel1452017-11-012023-04-07
Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women
Follitropin delta, Follitropin beta - Infertility
Phase 3CompletedFerring Pharmaceuticals3732017-07-292023-08-24
Hormone Evaluation in Artificial Reproductive Technology
Follitropin alpha, Menotropin - Female Infertility
Not applicableCompletedLund University8102016-09-012025-03-17
Role of FSHR Polymorphism p.N680S in the Therapy With FSH in Patients Who Underwent Varicocele Surgery
recombinant FSH - Infertility, Male, Varicocele
Phase 4UnknownU.O. Chirurgia Andrologica1002016-07-012016-03-25
Effectiveness and Safety Study of Fixed Versus Flexible of Gonadotropin-releasing Hormone Antagonist Protocol
Follitropin Beta, Ganirelix, rhCG - Infertility
Not applicableUnknownChong Qing Reproducive and Genetic Institute2002016-01-012015-12-21
Tailored Ovarian Stimulation Based on BMI, AMH, AFC
recFSH - Infertility
Phase 4UnknownCliniques universitaires Saint-Luc- Université Catholique de Louvain3002016-01-012023-04-12
Corifollitropin Alfa Versus Follitropin Beta in High Responders
Elonva, Puregon - Infertility
Phase 4UnknownEugonia622015-09-012015-06-22
Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients
corifollitropin alfa, Follitropin Beta - Infertility
Phase 4CompletedVietnam National University4002015-06-012017-08-22
A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment
FE 999049, follitropin beta - Infertility
Phase 2CompletedFerring Pharmaceuticals1592014-12-012020-12-14
Use of Corifolitropin Alfa in Oocyte Donors
Corifollitropin alfa, Recombinant FSH, HP-hMG - Female Reproductive Problem, Infertility
Phase 4UnknownIVI Madrid3002014-10-012015-07-17
Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF
Human Growth Hormone, Follicle Stimulating Hormone - Female Infertility Due to Diminished Ovarian Reserve
Phase 1 / Phase 2UnknownCenter for Human Reproduction302014-08-012020-02-18

Showing 20 of 54. Sign in to see all of them.

Conditions studied

Infertility (32)  ·  Infertility, Female (6)  ·  Congenital Abnormalities (4)  ·  Helping Behavior (3)  ·  Polycystic Ovary Syndrome (3)  ·  Primary Ovarian Insufficiency (2)  ·  Aneuploidy (1)  ·  Anovulation (1)  ·  Genital Diseases, Female (1)  ·  Infertility, Male (1)  ·  Uterine Diseases (1)  ·  Varicocele (1)

Sponsors

Organon and Co (15)  ·  Ferring Pharmaceuticals (5)  ·  Eugonia (2)  ·  Universitair Ziekenhuis Brussel (2)  ·  University Hospital, Ghent (2)  ·  ART Fertility Clinics LLC (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Bart CJM Fauser (1)  ·  Center for Human Reproduction (1)  ·  Chong Qing Reproducive and Genetic Institute (1)  ·  Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)  ·  Fundación Santiago Dexeus Font (1)  ·  Hospital de Clinicas de Porto Alegre (1)  ·  Houston Fertility Institute (1)  ·  IRCCS San Raffaele (1)

Countries

Belgium (7)  ·  United States (6)  ·  Spain (4)  ·  Greece (3)  ·  Netherlands (3)  ·  Japan (2)  ·  Norway (2)  ·  Poland (2)  ·  Sweden (2)  ·  Austria (1)  ·  Brazil (1)  ·  China (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Germany (1)

Top investigators

Antonio Requena, MD, PhD (1)  ·  Arne Sunde, phd (1)  ·  Barbara Lawrenz, PhD (1)  ·  Bart C Fauser, Prof, PhD (1)  ·  Ben Cohlen, dr. (1)  ·  Christoph Keck, PD, Dr. med. (1)  ·  Christophe Blockeel, MD (1)  ·  David H Barad, MD (1)  ·  Dilorom Kamilova, PhD (1)  ·  Dominic Stoop, MD, PhD (1)  ·  Efstratios M Kolibianakis, MD, MSc, PhD (1)  ·  Enrico Papaleo, MD (1)  ·  Fei Gong, Doctor (1)

Results publications

PMID 22587997, PMID 26991902, PMID 20483664, PMID 22459628, PMID 26003273, PMID 26950065, PMID 27619773, PMID 12858870, PMID 15126522, PMID 18230195, PMID 18684735, PMID 19617207, PMID 19684043, PMID 20843746, PMID 22244781, PMID 22791757, PMID 23352098, PMID 23394782, PMID 23758821, PMID 24903202, PMID 24970684, PMID 25385669, PMID 25492411, PMID 26520396, PMID 27090863, PMID 30895237, PMID 33272623, PMID 33722477, PMID 33934703, PMID 34799275, PMID 34808697, PMID 35460400, PMID 35460412, PMID 37156263, PMID 42786378

NIH funding

2004 (3), 2023 (2)